Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis - Full Text View - ClinicalTrials.gov

Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis - Full Text View - ClinicalTrials.gov



NIAID Treatment Study for Allergic Eczema

Allergic eczema (a.k.a. “atopic dermatitis”) is much more common today than it was 30 years ago, affecting 10-20% of children around the world. Treatment cannot cure atopic dermatitis, but it can control it and NIAID researchers are testing a new approach to therapy.

You may be eligible to participate in the study if:

• You are at least 7 years old
• Your doctor has diagnosed you with atopic dermatitis
• Your rash is located on your forearm or elbow
• You are willing to make at least 4 visits to the NIH Clinical Center in Bethesda, Maryland, during the year-long study.

Read more about the clinical trial of Cutaneous Treatment Efficacy in Atopic Dermatitis (study ID NCT03018275) https://www.clinicaltrials.gov/ct2/show/NCT03018275.